149 related articles for article (PubMed ID: 9635873)
1. X-ray-induced lymphomagenesis in E mu-pim-1 transgenic mice: an investigation of the co-operating molecular events.
van der Houven van Oordt CW; Schouten TG; van Krieken JH; van Dierendonck JH; van der Eb AJ; Breuer ML
Carcinogenesis; 1998 May; 19(5):847-53. PubMed ID: 9635873
[TBL] [Abstract][Full Text] [Related]
2. Use of E mu-PIM-1 transgenic mice short-term in vivo carcinogenicity testing: lymphoma induction by benzo[a]pyrene, but not by TPA.
Kroese ED; Dortant PM; van Steeg H; van Oostrom CT; van der Houven van Oordt CW; van Kranen HJ; de Vries A; Wester PW; van Kreijl CF
Carcinogenesis; 1997 May; 18(5):975-80. PubMed ID: 9163683
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma induction by heterocyclic amines in E mu-pim-1 transgenic mice.
Sørensen IK; Kristiansen E; Mortensen A; van Kreijl C; Adamson RH; Thorgeirsson SS
Arch Toxicol Suppl; 1997; 19():377-86. PubMed ID: 9079225
[TBL] [Abstract][Full Text] [Related]
4. Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice.
Sørensen IK; Mortensen A; Kristiansen E; van Kreijl C; Adamson RH; Thorgeirsson SS
Carcinogenesis; 1996 Oct; 17(10):2221-7. PubMed ID: 8895492
[TBL] [Abstract][Full Text] [Related]
5. Short-term carcinogenesis bioassay of genotoxic procarcinogens in PIM transgenic mice.
Storer RD; Cartwright ME; Cook WO; Soper KA; Nichols WW
Carcinogenesis; 1995 Feb; 16(2):285-93. PubMed ID: 7859360
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Emu-pim-1 transgenic mouse model for short-term carcinogenicity testing.
van Kreijl CF; van der Houven van Oordt CW; Kroese ED; Sørensen IK; Breuer ML; Storer RD
Toxicol Pathol; 1998; 26(6):750-6. PubMed ID: 9864091
[TBL] [Abstract][Full Text] [Related]
7. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
8. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc.
Allen JD; Verhoeven E; Domen J; van der Valk M; Berns A
Oncogene; 1997 Sep; 15(10):1133-41. PubMed ID: 9294606
[TBL] [Abstract][Full Text] [Related]
9. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.
Scheijen B; Jonkers J; Acton D; Berns A
J Virol; 1997 Jan; 71(1):9-16. PubMed ID: 8985317
[TBL] [Abstract][Full Text] [Related]
10. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice as a means to study synergism between oncogenes.
Berns A; Breuer M; Verbeek S; van Lohuizen M
Int J Cancer Suppl; 1989; 4():22-5. PubMed ID: 2681009
[TBL] [Abstract][Full Text] [Related]
12. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas.
Zhuang SM; Schippert A; Haugen-Strano A; Wiseman RW; Söderkvist P
Oncogene; 1998 Feb; 16(6):803-8. PubMed ID: 9488045
[TBL] [Abstract][Full Text] [Related]
13. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
14. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.
Schmidt T; Zörnig M; Beneke R; Möröy T
Nucleic Acids Res; 1996 Jul; 24(13):2528-34. PubMed ID: 8692692
[TBL] [Abstract][Full Text] [Related]
15. A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fields.
Harris AW; Basten A; Gebski V; Noonan D; Finnie J; Bath ML; Bangay MJ; Repacholi MH
Radiat Res; 1998 Mar; 149(3):300-7. PubMed ID: 9496894
[TBL] [Abstract][Full Text] [Related]
16. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
[TBL] [Abstract][Full Text] [Related]
17. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
Suchman EL; Pattengale PK; Fan H
J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
[TBL] [Abstract][Full Text] [Related]
18. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
19. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
van Lohuizen M; Verbeek S; Krimpenfort P; Domen J; Saris C; Radaszkiewicz T; Berns A
Cell; 1989 Feb; 56(4):673-82. PubMed ID: 2537153
[TBL] [Abstract][Full Text] [Related]
20. Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2.
van der Lugt NM; Domen J; Verhoeven E; Linders K; van der Gulden H; Allen J; Berns A
EMBO J; 1995 Jun; 14(11):2536-44. PubMed ID: 7781606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
